FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.
FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.
Advocates Oppose Proposals to Market Drugs After Phase I.
ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.
House Subcommittee Passes Bush Request for NIH, NCI Budgets.
NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
